News
12h
Zacks Investment Research on MSNPharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & MoreThis week, the European Commission granted marketing authorization to the expanded use of AbbVie’s ABBV Rinvoq and ...
Kidney transplant recipients with longer exposure to daily average temperatures of at least 86°F were more likely to experience worsening kidney function, graft failure and death from any cause, ...
An English teacher at Andover High School is teaching her students, and herself, lessons in empathy and patience.
23h
MedPage Today on MSNSoaring Temps Spell Trouble for Kidney Transplant RecipientsExposure to high temperatures may be renally taxing for kidney transplant recipients, a researcher reported here. Among ...
Adults recently diagnosed with immunoglobulin A nephropathy who were assigned sparsentan as first-line therapy experienced rapid and sustained reductions in proteinuria, according to ...
Chronic hepatitis B (CHB) is currently estimated to affect over 250 million people worldwide, and tenofovir disoproxil fumarate (TDF) is currently the most widely used antiviral agent for CHB ...
The US FDA has granted accelerated approval to atrasentan (Vanrafia) for reducing proteinuria in adults with primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results